Zusammenfassung
Der vulväre Lichen sclerosus (LS) ist eine nicht heilbare und progrediente Hauterkrankung unklarer Ätiologie. Er beginnt schleichend, verläuft unbehandelt bis zur destruktiven Atrophie und ist mit einem erhöhten Plattenepithelkarzinomrisiko assoziiert. Die klassischen Symptome sind Pruritus und Schmerzen, die Frühsymptome jedoch uncharakteristisch; daher werden unklare vulväre Beschwerden zunehmend bioptisch abgeklärt. Die histologischen Veränderungen eines frühen LS unterscheiden sich jedoch stark von denen eines späten LS mit flach-atropher Epidermis, hochgradig sklerosierter Dermis mit starr-ektatischen Gefäßen. Die Epidermis eines frühen LS ist meist normal mit nur geringen Unregelmäßigkeiten der Reteleisten. Die Basalmembran ist normal oder nur fokal minimal verbreitert, die ödematöse Dermis zeigt nur vereinzelt ektatische Gefäße. Das oft sehr dichte lichenoide und intraepidermale Infiltrat erklärt die Spongiose und Vakuolisierung der basalen Keratinozyten. Extrem frühe Formen zeigen nur ein spärliches Lymphozyteninfiltrat und Hyper-/Parakeratose der infundibulären Ostien. Eine frühe lokale Therapie kann das Fortschreiten zum atrophen irreversiblen LS verhindern.
Abstract
Vulvar lichen sclerosus (LS) is a chronic progressive skin disease of unclear etiology. It is often overlooked in early stages, but progresses to destructive atrophy and is associated with an increased risk of vulvar squamous cell carcinoma. The classical symptoms are pruritus and pain, but they are often not distinctive, so that unclear vulvar problems often lead to a biopsy. The histological picture of early LS is quite different from that of late LS with an atrophic epidermis, markedly sclerotic dermis and stiff dilated vessels. The epidermis in early LS is usually normal with only minor irregularities in the rete pattern. The basement membrane is normal or focally widened, while the edematous dermis has only scattered ectatic vessels. The often dense lichenoid and intraepidermal infiltrate explains the spongiosis and vacuolization of the basal layer keratinocytes. Very early cases may only have a sparse lymphocytic infiltrate and hyper-/parakeratosis of the follicular ostia. Early topical therapy can dampen the progression to atrophic, irreversible LS.
Literatur
Aberer E, Schmidt BL, Breier F et al. (1999) Amplification of DNA of Borrelia burgdorferi in urine samples of patients with granuloma annulare and lichen sclerosus et atrophicus. Arch Dermatol 135:210–212
Abramov Y, Elchalal U, Abramov D et al. (1996) Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 51:193–199
Azurdia RM, Luzzi GA, Byren I et al. (1999) Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol 140:79–83
Berkely CP, Bonney V (1909) Leukoplakic vulvitis and its relation to kraurosis vulvae and carcinoma vulvae. Br J Med 2:1739
Breisky D (1985) Über Kraurosis vulvae. Z Heilkd 6:69–80
Carli P, Cattaneo A, Magnis AD et al. (1995) Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prevention 4:491–495
Carli P, Morette S, Spallanzani A et al. (1997) Fibrinogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study. J Reprod Med 42:161–165
Carlson JA, Lamb P, Malfetano J et al. (1998) Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. Mod Pathol 11:844–854
Carlson JA, Grabowski R, Mu XC et al. (2002) Possible mechanism of hypopigmentation in lichen sclerosus. Am J Dermatopathol 24:97–107
Farrell AM, Dean D, Charnock FM, Wojnarowska F (2000) Alterations in distribution of tenascin, fibronectin and fibrinogen in vulval lichen sclerosus. Dermatology 201:223–229
Fisher GO (2001) Vulval disease in pre-pubertal girls. Australas J Dermatol 42:225–234
Friedrich EG, MacLaren NK (1984) Genetic aspects of vulvar lichen sclerosus. Am J Obstet Gynecol 150:161–166
Fung MA, LeBoit PE (1998) Light microscopic criteria for the diagnosis of early vulvar lichen sclerosus: a comparison with lichen planus. Am J Surg Path 22:473–478
Goolamali SK, Barnes EW, Irvine WJ, Shuster S (1974) Organ specific antibodies in patients with lichen sclerosus. Br Med J 4:78–79
Harrington CI, Dunsmore IR (1981) An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol 104:563–566
Jeffcoate TNA (1966) Chronic vulval dystrophies. Am J Obstet Gynecol 95:61–74
Johnston JC, Sherwell S (1903) White spot disease. J Cutan Dis 21:302–307
Kaya G, Augsburger E, Stamenkovic I, Saurat JH (2000) Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus. J Invest Dermatol 115:1054–1058
Khumalo P, Booker S, Wojnarowski F (2001) Vulval punch biopsies: what is the experience of patients and do they alter management? J Obstet Gynecol 21:181–183
Lukowsky A, Muche JM, Sterry W, Audring H (2000) Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol 115:254–259
Meyrick Thomas RH, Ridley CM, Black MM (1983) The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol 109:661–664
Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM (1988) Lichen sclerosus et atrophicus and autoimmunity—a study of 350 women. Br J Dermatol 118:41–46
Montgomery FH, Ormsby OS (1907) White spot disease (morphea guttata) and lichen planus sclerosus et atrophicus. J Cutan Dis 25:1–16
Neill SM, Tatnall FM, Cox NH (2002) Guidelines for the management of lichen sclerosus. Br J Dermatol 147:640–649
Nyirjesy P (2002) Lichen sclerosus and other conditions mimicking vulvovaginal Candidiasis. Curr Infect Dis Rep 4:520–524
Powell JJ, Wojnarowska F (1999) Lichen sclerosus. Lancet 353:1777–1783
Powell J, Wojnarowska F (2001) Childhood vulvar lichen sclerosus: An increasingly common problem. J Am Acad Dermatol 44:803–806
Powell J, Wojnarowska F, Winsey S et al. (2000) Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 142:481–484
Regauer S, Reich O, Beham-Schmid C (2002) Monoclonal gamma T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am J Pathol 160:1035–1045
Ridley CM, Frankman O, Jones ISC et al. (1989) New nomenclature for vulvar disease. International Society for the study of vulvar disease. Hum Path 20:495–496
Sahn EE, Bluestein EL, Oliva S (1994) Familial lichen sclerosus et atrophicus in childhood. Pediatr Dermatol 11:160–163
Scurry J (1999) Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. Int J Gynecol Cancer 9:89–97
Scurry JP, Vanin K (1997) Vulvar squamous cell carcinoma and lichen sclerosus. Australas J Dermatol 38 [Suppl 1]:S20–25
Soini Y, Pollanen R, Autio-Harmainen H, Lehto VP (1997) Tenascin expression in lichen sclerosus. Int J Gynecol Pathol 16:313–318
Stühmer A (1928) Balanitits xerotica obliterans (post operationem) und ihre Beziehungen zur „Kraurosis glandis et preputii penis“. Arch Dermatol Syphilol 156:613–623
Tasker GL, Wojnarowska F (2003) Lichen sclerosus. Clin Exp Dermatol 28:128–133
Wallace HJ (1971) Lichen sclerosus et atrophicus (review). Trans St Johns Hosp Dermatol Soc 57:9–30
Weir RJ (1875) Ichtyosis of the tongue and vulva. NY Med J 21:240
Whimister IW (1965) The natural history of skin malignancy. Br J Dermatol 77:534–535
Danksagung
Die Autoren danken der Österreichischen Krebshilfe Steiermark für die Unterstützung dieser Publikation aus dem Projekt 04/2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Regauer, S., Liegl, B., Reich, O. et al. Lichen sclerosus vulvae. Hautarzt 55, 158–164 (2004). https://doi.org/10.1007/s00105-003-0645-8
Issue Date:
DOI: https://doi.org/10.1007/s00105-003-0645-8